RR

Ramasamy Rajendiran

Active Director Director DIN 10167462
DIN 10167462 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramasamy Rajendiran

Data last updated:

Ramasamy Rajendiran is a Director at Medever Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10167462
Primary Designation Director
Industry Pharma
First Appointment 17 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 20232023Active

Board colleagues of Ramasamy Rajendiran

NameDINCompanyDesignation
Rishikappur Alias Manoj10167463Medever Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medever Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ramasamy Rajendiran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramasamy Rajendiran

Ramasamy Rajendiran currently holds 1 directorship: Medever Pharmaceutical Private Limited (Director, since 17 May 2023).

Ramasamy Rajendiran was first appointed on 17 May 2023 as Director at Medever Pharmaceutical Private Limited.

The current boards of Ramasamy Rajendiran's companies include Rishikappur Alias Manoj (Medever Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available